Cargando…
Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study
BACKGROUND: For the two-thirds of patients with epilepsy who achieve seizure remission on antiseizure medications (ASMs), patients and clinicians must weigh the pros and cons of long-term ASM treatment. However, little work has evaluated how often ASM discontinuation occurs in practice. We describe...
Autores principales: | Terman, Samuel W., Niznik, Joshua D., Slinger, Geertruida, Otte, Willem M., Braun, Kees P. J., Aubert, Carole E., Kerr, Wesley T., Boyd, Cynthia M., Burke, James F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434838/ https://www.ncbi.nlm.nih.gov/pubmed/36050646 http://dx.doi.org/10.1186/s12883-022-02852-6 |
Ejemplares similares
-
Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy
por: Terman, Samuel W., et al.
Publicado: (2022) -
Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review
por: Terman, Samuel W., et al.
Publicado: (2023) -
Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members
por: Terman, Samuel W., et al.
Publicado: (2023) -
White matter abnormalities at a regional and voxel level in focal and generalized epilepsy: A systematic review and meta-analysis
por: Slinger, Geertruida, et al.
Publicado: (2016) -
Predictors of referral for long‐term EEG monitoring for Medicare beneficiaries with drug‐resistant epilepsy
por: Hill, Chloe E., et al.
Publicado: (2023)